Table 1 Descriptive statistics of patients included in the study
Total N = 86 | Control N = 22 (25.6%) | Mild N = 21 (24.4%) | Severe N = 21 (24.4%) | Critical N = 22 (25.6%) | P-value | ||
|---|---|---|---|---|---|---|---|
Sex | Male | 45 (52. %) | 9 (40.9%) | 11 (52. %) | 13 (61. %) | 12 (54. %) | 0.588 |
Female | 41 (47. %) | 13 (59.1%) | 10 (47. %) | 8 (38. %) | 10 (45. %) | ||
Age (years) | 52.5 [19.0, 91.8] | 43.0 [19.0, 58.0] | 49.9 [20.0, 82.7] | 61.7 [21.3, 91.8] | 60.8 [25.8, 84.4] | 0.001 | |
Anti-RBD IgE antibody titers | 0.21 [0.00, 3.34] | 0.20 [0.00, 0.55] | 0.11 [0.00, 1.17] | 0.27 [0.00, 2.03] | 0.28 [0.00, 3.34] | 0.329 | |
Days from first clinical symptoms to sample extraction | 7.0 [0.0, 38.0] | - | 4.0 [0.0, 20.0] | 7.0 [0.0, 15.0] | 9.0 [0.0, 38.0] | 0.039 | |